Generic Pharmaceutical Manufacturing in the US - IBISWorld Industry Market Research

Generic Pharmaceutical Manufacturing in the US

Generic Pharmaceutical Manufacturing in the US - IBISWorld Industry Market Research
Generic Pharmaceutical Manufacturing in the US
Published Sep 29, 2015
42 pages — Published Sep 29, 2015
Price US$ 910.00  |  Buy this Report Now

About This Report


An aging population with more chronic illnesses is driving demand for the Generic Pharmaceutical Manufacturing industry, while regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development. In the coming years, healthcare reform will benefit the industry through expanded insurance coverage for prescription drugs, an improved generic drug approval process and an established approval pathway for biosimilars.

Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.

Document ID
Report Type
PDF Adobe Acrobat
Buy Now

IBISWorld Industry Market Research—IBISWorld is a leading strategic business information provider that offers comprehensive information on more than 700 US industries covering 4,000 individual product segments. They also provide global industry and industry risk rating reports covering Australia, the United Kingdom and China. IBISWorld data offers detailed analysis on growth trends, the competitive environment and key issues. Reports average 30 to 40 pages and contain figures; market characteristics; product, market and service segmentation; industry conditions, current and historical performance analysis; risk scores; industry participants and market share; factors to success; and 5-year forecasts with forecast analysis.

About the Author

Cite this Report

IBISWorld Industry Market Research. "Generic Pharmaceutical Manufacturing in the US" Sep 29, 2015. Alacra Store. Oct 23, 2016. <>
IBISWorld Industry Market Research. (2015). Generic Pharmaceutical Manufacturing in the US Sep 29, 2015. New York, NY: Alacra Store. Retrieved Oct 23, 2016 from <>
US$ 910.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.